Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.80 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.80 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.71 |
| ▸ | STAT6 | P42226 | 1/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.69 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.68 |
| ▸ | HPGD | P15428 | 3/20 | 0.68 |
| ▸ | POLB | P06746 | 2/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | HTR1A | P08908 | 1/20 | 0.65 |
| ▸ | HTR2A | P28223 | 1/20 | 0.65 |
| ▸ | HTR7 | P34969 | 1/20 | 0.65 |
| ▸ | APEX1 | P27695 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29395006 | 1.00 | CYP1A2 (0.80) | CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL28621136 | 0.90 | CYP1A2 (0.75) | CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL5837665 | 0.89 | CYP1A2 (1.00) | CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL7401382 | 0.87 | CYP1A2 (0.71) | CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL15501200 | 0.85 | CYP1A2 (0.67) | CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL6141647 | 0.84 | CYP1A2 (0.83) | CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL25123680 | 0.84 | CYP1A2 (0.65) | CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL8089129 | 0.83 | FBP1 (0.67) | CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL9532439 | 0.83 | CYP1A2 (0.80) | CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL10764021 | 0.83 | CYP1A2 (1.00) | CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008048554-A2 | IMPROVED EPOXY COMPOSITIONS | TRILLION SCIENCE, INC. (US) | 2008-04-24 | — | — | WO | claimed |
| US-20080090943-A1 | Leuco dyes with a N,N-dialkylamino, N,N-diarylamino, N-alkyl-N-arylamino, N-alkylamino, or N-arylamino group on one of the aromatic rings and a latent curing agent or catalyst activate-able by heat, pressure, or radiation | TRILLION, INC. | 2008-04-17 | — | — | US | claimed |
| CN-115362203-B | Moisture-curable non-yellowing clear compositions and methods of making the same | 迈图高新材料公司 | 2024-07-16 | — | — | CN | disclosed |
| US-11859043-B2 | Moisture-curable silylated polymer resin composition with reduced moisture sensitivity | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2024-01-02 | — | — | US | disclosed |
| US-20230106223-A1 | MOISTURE-CURABLE NON-YELLOWING CLEAR COMPOSITION AND METHOD OF MAKING THEREOFROM | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-04-06 | — | — | US | disclosed |
| EP-4157911-A1 | MOISTURE-CURABLE SILYLATED POLYMER RESIN COMPOSITION WITH REDUCED MOISTURE SENSITIVITY | Momentive Performance Materials Inc. (US) | 2023-04-05 | — | — | EP | disclosed |
| EP-4081585-A1 | MOISTURE-CURABLE NON-YELLOWING CLEAR COMPOSITION AND METHOD OF MAKING THEREOFROM | Momentive Performance Materials Inc. (US) | 2022-11-02 | — | — | EP | disclosed |
| CN-115209790-A | Specific THC detection device | 韦里特克美国有限公司 | 2022-10-18 | — | — | CN | disclosed |
| US-20220291245-A1 | SPECIFIC THC DETECTION DEVICE | VERITEQUE USA, INC. | 2022-09-15 | — | — | US | disclosed |
| EP-4048141-A1 | SPECIFIC THC DETECTION DEVICE | Veriteque USA, Inc. (US) | 2022-08-31 | — | — | EP | disclosed |
| CN-110447997-B | Cool and comfortable fabric | 江苏大毛牛新材料有限公司 | 2022-02-25 | — | — | CN | disclosed |
| EP-1382600-B1 | Curable compositions containing thiazole functionality | NAT STARCH CHEM INVEST (US) | 2005-05-04 | — | — | EP | disclosed |
| EP-1512704-A1 | High refractive index, UV-curable monomers and coating compositions prepared therefrom | GENERAL ELECTRIC COMPANY (US) | 2005-03-09 | — | — | EP | disclosed |
| US-20050049325-A1 | Method of making a high refractive index optical management coating and the coating | CITIBANK, N.A., AS COLLATERAL AGENT | 2005-03-03 | — | — | US | disclosed |
| EP-1423363-A1 | ORAL ANTIDIABETIC AGENTS | Warner-Lambert Company LLC (US) | 2004-06-02 | — | — | EP | disclosed |
| US-6706835-B2 | ADHESION PROMOTERS; HIGH STRENGTH BONDING TO METALS; SEMICONDUCTORS, INTEGRATED CIRCUITS | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2004-03-16 | — | — | US | disclosed |
| US-20040014903-A1 | CURABLE COMPOSITIONS CONTAINING THIAZOLE FUNCTIONALITY | HENKEL AG & CO. KGAA (DE) | 2004-01-22 | — | — | US | disclosed |
| EP-1382600-A1 | Curable compositions containing thiazole functionality | National Starch and Chemical Investment Holding Corporation (US) | 2004-01-21 | — | — | EP | disclosed |
| US-20030171377-A1 | Antidiabetic agents | BIGGE CHRISTOPHER FRANKLIN (US) | 2003-09-11 | — | — | US | disclosed |
| WO-2003018553-A1 | ORAL ANTIDIABETIC AGENTS | WARNER-LAMBERT COMPANY LLC (US) | 2003-03-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171377-A1 | Antidiabetic agents | SLC5A1, SLC5A2, GLP1R | CYP1A2 971/4885CYP2D6 140/4885CYP2C19 343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.